Krka reports lower Jan-Sep profit on higher sales

Ljubljana, 16 November - Slovenia's pharma group Krka saw its net profit fall by 22% year-on-year to EUR 235.6 million in the first nine months of the year despite sales revenue rising by 8% to EUR 1.34 billion.